SEC Form 4 research
| Issuer | ACADIA PHARMACEUTICALS INC |
|---|---|
| Tickers | ACAD |
| Reporting owners | 47 |
| Officers and directors | 25 |
| Last public filing | 2026-10-31 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-30 | 2026-10-30 | Schneyer Mark C. | S | 3,321 | $20.88 | Not reported |
| 2026-10-30 | 2026-10-15 | Schneyer Mark C. | A | 6,815 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.